Wolf in sheep’s clothing? How to assess aggressiveness of osteoblastomas of the spine
BY DR FENG WEI
About the author:
Dr Feng Wei is Associate Professor at the Orthopaedic Department of Peking University Third Hospital Beijing, China. His primary interest is in surgery of spine tumor and all kinds of degenerative spinal diseases.
References and further reading:
- Amary F, et al. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool. Am J Surg Pathol. 2019;43(12):1661-1667
Bertoni, et al. The morphologic spectrum of osteoblastoma (OBL): is its ‘aggressive’ nature predictable? Mod Pathol. 1993; 7:6A - Boriani S, et al. Staging and treatment of osteoblastoma in the mobile spine: a review of 51 cases. Eur Spine J. 2012 Oct;21(10):2003-10. doi: 10.1007/s00586-012-2395-8
- Della,et al. Osteoblastoma: do histologic features predict clinical behavior? A study of 55 patients. Mod Pathol. 1994; 7:6A.
- Filippi, et al. Epithelioid multinodular osteoblastoma: a clinicopathologic analysis of 26 cases. Am J Surg Pathol. 2007 Aug;31(8):1265-8.
- Lucas, et al. Osteoblastoma: a clinicopathologic study of 306 cases. Hum Pathol. 1994; 25:117–134.
- Schajowicz F, Lemos C. Malignant osteoblastoma. J Bone Joint Surg Br 1976; 58:202–11.
You could also be interested in:
Video lectures by AO Spine Knowledge Forum Tumor
This article is part of a series of lectures by the AO Spine Knowledge Forum Tumor.
Targeted therapies in cancer treatment
AO Spine Guest Blog article by Dr Chetan Bettegowda.
AO Video Hub
A vast collection of recorded lectures and webinars are available in the AO Video Hub for AO members.
AO Spine Knowledge Forum Tumor
International group of dedicated spine oncology surgeons and oncologists leading the way in spine oncology research.
Disclaimer
The articles included in the AO Spine Blog represent the opinion of individual authors exclusively and not necessarily the opinion of AO Spine or AO Foundation.